Literature DB >> 21553352

Slouching towards gene therapy for hypercholesterolemia.

Friedrich C Luft1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21553352     DOI： 10.1007/s00109-011-0765-z

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  9 in total

1.  Gene therapy death prompts review of adenovirus vector.

Authors:  E Marshall
Journal:  Science       Date:  1999-12-17       Impact factor: 47.728

2.  Direct comparison of hepatocyte-specific expression cassettes following adenoviral and nonviral hydrodynamic gene transfer.

Authors:  F Jacobs; J Snoeys; Y Feng; E Van Craeyveld; J Lievens; D Armentano; S H Cheng; B De Geest
Journal:  Gene Ther       Date:  2008-02-21       Impact factor: 5.250

3.  Recombinational construction in Escherichia coli of infectious adenoviral genomes.

Authors:  J Crouzet; L Naudin; C Orsini; E Vigne; L Ferrero; A Le Roux; P Benoit; M Latta; C Torrent; D Branellec; P Denèfle; J F Mayaux; M Perricaudet; P Yeh
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

4.  Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

Authors:  Steven E Nissen; Stephen J Nicholls; Ilke Sipahi; Peter Libby; Joel S Raichlen; Christie M Ballantyne; Jean Davignon; Raimund Erbel; Jean Charles Fruchart; Jean-Claude Tardif; Paul Schoenhagen; Tim Crowe; Valerie Cain; Kathy Wolski; Marlene Goormastic; E Murat Tuzcu
Journal:  JAMA       Date:  2006-03-13       Impact factor: 56.272

5.  Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis.

Authors:  Sadik H Kassim; Hui Li; Luk H Vandenberghe; Christian Hinderer; Peter Bell; Dawn Marchadier; Aisha Wilson; Debra Cromley; Valeska Redon; Hongwei Yu; James M Wilson; Daniel J Rader
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

6.  Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs.

Authors:  Olivia C Hibbitt; Eileen McNeil; Michele Mp Lufino; Len Seymour; Keith Channon; Richard Wade-Martins
Journal:  Mol Ther       Date:  2009-10-27       Impact factor: 11.454

7.  Adenoviral low density lipoprotein receptor attenuates progression of atherosclerosis and decreases tissue cholesterol levels in a murine model of familial hypercholesterolemia.

Authors:  Frank Jacobs; Eline Van Craeyveld; Yingmei Feng; Jan Snoeys; Bart De Geest
Journal:  Atherosclerosis       Date:  2008-03-04       Impact factor: 5.162

Review 8.  Current status of cardiovascular gene therapy.

Authors:  Tuomas T Rissanen; Seppo Ylä-Herttuala
Journal:  Mol Ther       Date:  2007-05-08       Impact factor: 11.454

9.  Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies.

Authors:  Eline Van Craeyveld; Stephanie C Gordts; Elena Nefyodova; Frank Jacobs; Bart De Geest
Journal:  J Mol Med (Berl)       Date:  2011-01-21       Impact factor: 4.599
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.